Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Immunology Secreted Molecules CCN Family

Recombinant human WISP3 protein (ab50049)

Key features and details

  • Expression system: Escherichia coli
  • Endotoxin level:
  • Active: Yes
  • Suitable for: SDS-PAGE, Functional Studies

You may also be interested in

Product image
Anti-WISP3 antibody (ab224720)
Product image
Anti-WISP3 antibody [EPR14769] - BSA and Azide free (ab250940)
Product image
Anti-WISP3 antibody [EPR14769] - C-terminal (ab187666)
Product image
Anti-WISP3 antibody (ab103263)

Description

  • Product name

    Recombinant human WISP3 protein
  • Endotoxin level

  • Expression system

    Escherichia coli
  • Protein length

    Full length protein
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human
    • Sequence

      TGPLDTTPEG RPGEVSDAPQ RKQFCHWPCK CPQQKPRCPP GVSLVRDGCG CCKICAKQPG EICNEADLCD PHKGLYCDYS VDRPRYETGV CAYLVAVGCE FNQVHYHNGQ VFQPNPLFSC LCVSGAIGCT PLFIPKLAGS HCSGAKGGKK SDQSNCSLEP LLQQLSTSYK TMPAYRNLPL IWKKKCLVQA TKWTPCSRTC GMGISNRVTN ENSNCEMRKE KRLCYIQPCD SNILKTIKIP KGKTCQPTFQ LSKAEKFVFS GCSSTQSYKP TFCGICLDKR CCIPNKSKMI TIQFDCPNEG SFKWKMLWIT SCVCQRNCRE PGDIFSELKI L
  • Associated products

    • Related Products

      • Anti-WISP3 antibody (ab103263)

    Specifications

    Our Abpromise guarantee covers the use of ab50049 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    • Applications

      SDS-PAGE

      Functional Studies

    • Form

      Lyophilized
    • Concentration information loading...

    Preparation and Storage

    • Stability and Storage

      Shipped at 4°C. The lyophilized protein is stable for a few weeks at room temperature. Store at -20°C long term.

      This product is an active protein and may elicit a biological response in vivo, handle with caution.

    • Reconstitution
      For lot specific reconstitution information please contact our Scientific Support Team.

    General Info

    • Alternative names

      • CCN 6
      • CCN family member 6
      • CCN6
      • CYR61
      • LIBC
      • Lost in inflammatory breast cancer tumor suppressor protein
      • MGC125987
      • MGC125988
      • MGC125989
      • OTTHUMP00000040421
      • PPAC
      • PPD
      • UNQ462/PRO790/PRO956
      • WISP 3
      • WISP-3
      • WISP3
      • WISP3_HUMAN
      • WNT 1 inducible signaling pathway protein 3
      • Wnt 1 signaling pathway protein 3
      • WNT1 inducible signaling pathway protein 3
      • WNT1 inducible signaling pathway protein 3 precursor
      • WNT1-inducible-signaling pathway protein 3
      see all
    • Function

      Appears to be required for normal postnatal skeletal growth and cartilage homeostasis.
    • Tissue specificity

      Predominant expression in adult kidney and testis and fetal kidney. Weaker expression found in placenta, ovary, prostate and small intestine. Also expressed in skeletally-derived cells such as synoviocytes and articular cartilage chondrocytes.
    • Involvement in disease

      Defects in WISP3 are the cause of progressive pseudorheumatoid arthropathy of childhood (PPAC) [MIM:208230]. PPAC is an autosomal recessive disorder characterized by stiffness and swelling of joints, motor weakness and joint contractures. Signs and symptoms of the disease develop typically between three and eight years of age. This progressive disease is a primary disorder of articular cartilage with continued cartilage loss and destructive bone changes with aging.
    • Sequence similarities

      Belongs to the CCN family.
      Contains 1 CTCK (C-terminal cystine knot-like) domain.
      Contains 1 IGFBP N-terminal domain.
      Contains 1 TSP type-1 domain.
    • Cellular localization

      Secreted.
    • Target information above from: UniProt accession O95389 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt

Protocols

To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

Click here to view the general protocols

Datasheets and documents

    • Datasheet
  • References (0)

    Publishing research using ab50049? Please let us know so that we can cite the reference in this datasheet.

    ab50049 has not yet been referenced specifically in any publications.

    Preparation and Storage

    • Stability and Storage

      Shipped at 4°C. The lyophilized protein is stable for a few weeks at room temperature. Store at -20°C long term.

      This product is an active protein and may elicit a biological response in vivo, handle with caution.

    • Reconstitution
      For lot specific reconstitution information please contact our Scientific Support Team.

    Images

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-HNRPH2/HNRNPH2 antibody [EPR12170(B)] - BSA and Azide free (ab250086)

    •  
    • Product image

      Human Semaphorin 7A Antibody Pair - BSA and Azide free (ab253329)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.